4.3851.68% ( -0.075 )
Delay Closed: Nov 20, 16:08:00Valuation
Current ValuationThe current P/E ratio is 5.76, below the reasonable range, cheaper than 98.16% of the time in the past 5 years, and the industry ranks 3/54, the industry Median 7.34.
5.76xP/E
HK$4.39Stock price
HK$0.76Earnings per share
5.76xP/E
Stock priceHK$4.39Earnings per shareHK$0.76
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 8.16x
- Typical range
- 6.82x–9.33x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 7.34x
09182736
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 7.34x
0x20x40x60x80x100x
| Name/Symbol | |||
|---|---|---|---|
02196HKFOSUN PHARMA | 9.25x | 10.13% | HK$37.89B |
03320HKCHINARES PHARMA | 5.76x | 7.23% | HK$27.55B |
01681HKCONSUN PHARMA | 9.50x | 20.92% | HK$12.85B |
02877HKSHINEWAY PHARM | 7.57x | 13.28% | HK$7.01B |
02186HKLUYE PHARMA | 7.35x | 47.27% | HK$5.89B |
02633HKJACOBSON PHARMA | 5.90x | 1.99% | HK$1.78B |
08049HKJILIN CHANGLONG | 6.39x | -- | HK$1.61B |
02348HKDAWNRAYS PHARMA | 4.82x | -- | HK$1.29B |
02161HKJBM HEALTHCARE | 6.05x | 6.78% | HK$1.22B |
00239HKPAK FAH YEOW | 7.34x | -- | HK$726.12M |
00950HKLEE'S PHARM | 4.94x | -- | HK$591.78M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
